UID:
almahu_9949434921902882
Format:
1 online resource
Edition:
First edition.
ISBN:
9781003248156
,
1003248152
,
9781000788068
,
1000788067
,
9781000788112
,
1000788113
Content:
"This book is the most comprehensive and complete treatise on nucleic acid therapeutic products, including mRNA vaccines, their manufacturing, formulations, and testing for safety and efficacy testing. Details include cGMP-compliant manufacturing and regulatory filing steps. A new concept of "biosimilar" mRNA vaccine is presented to secure fast approval of copies of mRNA vaccines. Projections of financial plans to establish RNA manufacturing facilities are provided, along with details of supply chain management. Finally, the future of nucleic acid products in gene therapy and other newer applications is presented, along with a perspective that all new vaccines will be the nucleic acid type that will further provide first-time prevention of autoimmune disorders. It is projected that both big pharma and startups will enter this field, and we can expect significant additions to our drug armamentarium soon"--
Note:
The genome machine -- Understanding nucleic acids -- RNA therapeutics -- Nucleoside vaccines -- cGMP mRNA vaccine manufacturing -- Regulatory guidance.
Additional Edition:
Print version: Niazi, Sarfaraz, 1949- mRNA therapeutics Boca Raton : CRC Press, 2023 ISBN 9781032163444
Language:
English
DOI:
10.1201/9781003248156
URL:
https://www.taylorfrancis.com/books/9781003248156
Bookmarklink
